SG11201508999UA - A method of determining virus removal from a sample containing a target protein using activated carbon - Google Patents

A method of determining virus removal from a sample containing a target protein using activated carbon

Info

Publication number
SG11201508999UA
SG11201508999UA SG11201508999UA SG11201508999UA SG11201508999UA SG 11201508999U A SG11201508999U A SG 11201508999UA SG 11201508999U A SG11201508999U A SG 11201508999UA SG 11201508999U A SG11201508999U A SG 11201508999UA SG 11201508999U A SG11201508999U A SG 11201508999UA
Authority
SG
Singapore
Prior art keywords
activated carbon
target protein
sample containing
virus removal
determining virus
Prior art date
Application number
SG11201508999UA
Other languages
English (en)
Inventor
Matthew T Stone
Ushma Mehta
Damon Asher
Patricia Greenhalgh
Original Assignee
Emd Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emd Millipore Corp filed Critical Emd Millipore Corp
Publication of SG11201508999UA publication Critical patent/SG11201508999UA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/20Partition-, reverse-phase or hydrophobic interaction chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06Quantitative determination
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/015Parvoviridae, e.g. feline panleukopenia virus, human Parvovirus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201508999UA 2013-07-12 2014-04-04 A method of determining virus removal from a sample containing a target protein using activated carbon SG11201508999UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361845429P 2013-07-12 2013-07-12
PCT/US2014/032940 WO2015005961A1 (en) 2013-07-12 2014-04-04 A method of determining virus removal from a sample containing a target protein using activated carbon

Publications (1)

Publication Number Publication Date
SG11201508999UA true SG11201508999UA (en) 2015-11-27

Family

ID=50943530

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201508999UA SG11201508999UA (en) 2013-07-12 2014-04-04 A method of determining virus removal from a sample containing a target protein using activated carbon

Country Status (8)

Country Link
US (1) US9910041B2 (ja)
EP (1) EP3019521A1 (ja)
JP (3) JP2016529885A (ja)
KR (1) KR101894762B1 (ja)
CN (1) CN105339388B (ja)
CA (1) CA2912765C (ja)
SG (1) SG11201508999UA (ja)
WO (1) WO2015005961A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2737539C2 (ru) 2016-04-01 2020-12-01 Юсб Биофарма Спрл Способ очистки белка
EP3249406A1 (de) 2016-05-27 2017-11-29 PerkinElmer Cellular Technologies Germany GmbH Verfahren zur bestimmung der anzahl von infektionsherden einer zellkultur
WO2018043645A1 (ja) * 2016-08-31 2018-03-08 協和発酵キリン株式会社 活性炭を用いた蛋白質の精製方法
EP3916001A4 (en) 2019-01-23 2022-10-19 Daiichi Sankyo Company, Limited ONE-STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES USING ACTIVATED CARBON MATERIAL

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31093A (en) 1861-01-08 Mode of constructing iron pavements
US3770625A (en) 1971-04-19 1973-11-06 Carborundum Co Removal of virus from fluids
JPS4976329A (ja) 1972-10-20 1974-07-23
US4116768A (en) 1975-04-29 1978-09-26 (Zaidanhojin) Sagami Chemical Research Center Process for producing a peptide
CA1189810A (en) 1982-02-22 1985-07-02 Chifa F. Lin Process for the preparation of protein for hydrolysis
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8923662D0 (en) 1989-10-20 1989-12-06 Norit Uk Ltd A method of producing granular activated carbon
US5179104A (en) 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5204310A (en) 1992-02-21 1993-04-20 Westvaco Corporation High activity, high density activated carbon
JPH05292986A (ja) 1992-02-21 1993-11-09 Takeda Chem Ind Ltd トレハロースの製造法
US5639376A (en) 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
WO1996002563A1 (en) 1994-07-13 1996-02-01 Cornell Research Foundation, Inc. Epstein-barr virus nuclear antigen 1 protein and its expression and recovery
US5668263A (en) 1994-12-16 1997-09-16 Smithkline Beecham Corporation Conserved yeast nucleic acid sequences
US5714354A (en) 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
ES2337852T3 (es) * 1995-06-07 2010-04-29 Cerus Corporation Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos.
WO1997003092A1 (en) 1995-07-13 1997-01-30 Hemasure A/S A process for removal of polyethylene glycol from a protein or peptide solution
AU6267596A (en) 1995-12-14 1997-07-03 Steritech, Inc. Inactivation of non-enveloped virus
JP2732379B2 (ja) 1995-12-18 1998-03-30 日本臓器製薬株式会社 知覚異常改善剤
JPH09169648A (ja) 1995-12-22 1997-06-30 Nippon Shinyaku Co Ltd 医薬組成物
DE19705366C2 (de) 1997-02-12 2002-08-01 Fresenius Ag Trägermaterial zur Reinigung proteinhaltiger Lösungen, Verfahren zur Herstellung des Trägermaterials und Verwendung des Trägermaterials
US6783713B2 (en) 1999-05-03 2004-08-31 The Procter & Gamble Co. Filters for removal of pathogens from liquids
WO2001052838A1 (en) 2000-01-20 2001-07-26 Baker Norton Pharmaceuticals, Inc. Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof
WO2005016246A2 (en) 2003-06-20 2005-02-24 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
US7390403B2 (en) 2004-03-19 2008-06-24 Millipore Corporation Prefilter system for biological systems
US20060029612A1 (en) 2004-04-15 2006-02-09 Large Scale Biology Corporation Prevention and treatment of recurrent respiratory papillomatosis
US20060281075A1 (en) 2004-12-22 2006-12-14 Large Scale Biology Corporation Purification of viruses, proteins and nucleic acids
US20060251761A1 (en) 2005-05-03 2006-11-09 Robert Jansen Grain wet milling process for producing dextrose
WO2007017111A1 (en) 2005-07-28 2007-02-15 Pall Corporation Filter module and process for manufacture of same
FR2891747B1 (fr) 2005-10-10 2007-12-14 Maco Pharma Sa Unite de filtration pour l'elimination selective d'une substance cible
EP2041155B1 (en) * 2006-06-26 2020-01-08 Omrix Biopharmaceuticals Inc. Virus removal by nanofiltration
US8652480B2 (en) 2007-03-23 2014-02-18 Wyeth Llc Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
AR082319A1 (es) 2010-07-22 2012-11-28 Biomarin Pharm Inc Produccion de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos
SG189872A1 (en) * 2010-10-11 2013-06-28 Abbvie Inc Processes for purification of proteins
WO2013028330A2 (en) * 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification

Also Published As

Publication number Publication date
CN105339388A (zh) 2016-02-17
WO2015005961A1 (en) 2015-01-15
JP6914204B2 (ja) 2021-08-04
CA2912765A1 (en) 2015-01-15
JP2020072710A (ja) 2020-05-14
KR20160003726A (ko) 2016-01-11
US20160123981A1 (en) 2016-05-05
JP2016529885A (ja) 2016-09-29
JP2018085993A (ja) 2018-06-07
CA2912765C (en) 2018-05-01
KR101894762B1 (ko) 2018-09-05
US9910041B2 (en) 2018-03-06
EP3019521A1 (en) 2016-05-18
CN105339388B (zh) 2021-06-15

Similar Documents

Publication Publication Date Title
PL3071046T3 (pl) Sposób ekstrahowania białek grochu
SG10201801428RA (en) Method for increasing expression of rna-encoded proteins
LT3201336T (lt) Nedenatūruotų baltymų ekstrahavimo ir valymo būdai
HRP20190055T1 (hr) Metode detekcije podrijetla vrsta iz uzoraka
GB2537077B (en) Methods for sequencing nucleic acids
EP2971159A4 (en) Methods for analyzing nucleic acids
IL249729A0 (en) Methods and materials for cleaning proteins
SG10201500862RA (en) A Method for Detecting a Target Analyte
SG11201802706YA (en) Method for extracting substance from feces sample
GB201415761D0 (en) Methods for detection of Nucleotide modification
GB2532790B (en) Modified pipette tips for chromatin immunoprecipitation assay
EP3054283A4 (en) Method for detecting target substance
SG10201607279RA (en) Method for characterizing material by analysis of speckles
EP3362464A4 (en) Methods for extracting proteins from blood plasma
SG11201508999UA (en) A method of determining virus removal from a sample containing a target protein using activated carbon
SG11201508835YA (en) Removal of fragments from a sample containing a target protein using activated carbon
GB201402347D0 (en) Fixative solution for materials or samples of biological origin
SG11201704540YA (en) Method for purifying easily polymerizable substance
EP3128327A4 (en) Method for detecting smn protein expression
HUE043795T2 (hu) Eljárás klasszikus sertéspestis vírusának specifikus detektálására
IL247996B (en) A method for detecting changes in proteins
GB201315532D0 (en) Methods for detecting proteins
IL245222B (en) A method for discovering DNA
PL3158337T3 (pl) Sposoby określania i ryzyka cukrzycy typu 1 przez biomarkery białkowe w surowicy
IL246958B (en) A method for analyzing blood samples to detect pathologies